Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation.

Mohamad SB, Nagasawa H, Uto Y, Hori H.

Comp Biochem Physiol A Mol Integr Physiol. 2002 May;132(1):1-8.

PMID:
12062184
2.

Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.

Koga Y, Naraparaju VR, Yamamoto N.

Proc Soc Exp Biol Med. 1999 Jan;220(1):20-6.

PMID:
9893164
4.

Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.

Yamamoto N, Suyama H, Nakazato H, Yamamoto N, Koga Y.

Cancer Immunol Immunother. 2008 Jul;57(7):1007-16. Retraction in: Cancer Immunol Immunother. 2014 Dec;63(12):1349.

PMID:
18058096
5.
6.
7.

Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF).

Yamamoto N, Ushijima N, Koga Y.

J Med Virol. 2009 Jan;81(1):16-26. doi: 10.1002/jmv.21376. Retraction in: J Med Virol. 2014 Nov;86(11):1998.

PMID:
19031451
8.
9.

The Effect of Fucoidan from the Brown Alga Fucus evanescence on the Activity of α-N-Acetylgalactosaminidase of Human Colon Carcinoma Cells.

Bakunina I, Chadova O, Malyarenko O, Ermakova S.

Mar Drugs. 2018 May 10;16(5). pii: E155. doi: 10.3390/md16050155.

10.

GC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients.

Thyer L, Ward E, Smith R, Branca JJ, Morucci G, Gulisano M, Noakes D, Eslinger R, Pacini S.

Oncoimmunology. 2013 Aug 1;2(8):e25769. Epub 2013 Jul 29.

11.

Degalactosylated/desialylated human serum containing GcMAF induces macrophage phagocytic activity and in vivo antitumor activity.

Kuchiike D, Uto Y, Mukai H, Ishiyama N, Abe C, Tanaka D, Kawai T, Kubo K, Mette M, Inui T, Endo Y, Hori H.

Anticancer Res. 2013 Jul;33(7):2881-5.

PMID:
23780974
12.
13.

Structural modification of serum vitamin D3-binding protein and immunosuppression in AIDS patients.

Yamamoto N, Naraparaju VR, Srinivasula SM.

AIDS Res Hum Retroviruses. 1995 Nov;11(11):1373-8.

PMID:
8573395
14.

Is α-N-acetylgalactosaminidase the key to curing cancer? A mini-review and hypothesis.

Saburi E, Tavakol-Afshari J, Biglari S, Mortazavi Y.

J BUON. 2017 Nov-Dec;22(6):1372-1377. Review.

15.

Gc protein-derived macrophage activating factor (GcMAF): isoelectric focusing pattern and tumoricidal activity.

Mohamad SB, Nagasawa H, Sasaki H, Uto Y, Nakagawa Y, Kawashima K, Hori H.

Anticancer Res. 2003 Nov-Dec;23(6a):4451-7.

PMID:
14666733
16.
18.

Serum alpha-N-acetylgalactosaminidase is associated with diagnosis/prognosis of patients with squamous cell carcinoma of the uterine cervix.

Reddi AL, Sankaranarayanan K, Arulraj HS, Devaraj N, Devaraj H.

Cancer Lett. 2000 Sep 29;158(1):61-4.

PMID:
10940510
19.

A novel assay system for macrophage-activating factor activity using a human U937 cell line.

Ishikawa M, Inoue T, Inui T, Kuchiike D, Kubo K, Uto Y, Nishikata T.

Anticancer Res. 2014 Aug;34(8):4577-81.

PMID:
25075102

Supplemental Content

Support Center